Hence, the increase in CRP levels following IL-6 upregulation may not only represent a reaction to tumor progression but also signify tissue inflammation and damage, which could potentially function as a mechanism linking low mGNRI levels and unfavorable survival outcomes. This evidence concerns the gene IL6 and neoplasm.